Market-Research-News

  What This Report Will Provide: This study involved four major activities in estimating the current size of the healthcare it market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments. Expected Revenue Growth: The global Healthcare IT Market size is projected to reach USD 270.3 billion by 2021 from USD 227.5 billion in 2020, at a CAGR of 23.6%. Major Growth Boosters: The market for healthcare information technology is driven primarily by the rising incidence of COVID-19, government mandates, support and initiatives for HCIT solutions, the increasing u

  Immuno-Oncology Assays: Market Overview: The growth of this market is primarily driven by factors such as the increasing adoption of targeted therapy over traditional therapy and increasing demand for mAbs. However, the high cost of immunotherapy treatment and the high attrition rate in the product development cycle are the major factors that are expected to restrain the growth of this market during the forecast period. The market for immuno-oncology assays is expected to reach USD 5.9 billion by 2024 from USD 2.9 billion in 2018, at a CAGR of 12.7%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=52562166 In-Depth Market Segmentation: Products: Based on products, the immuno-oncology assays market is segmented into consumables and software. The consumables segment dominated the market with the largest share in 2018; this segment is also expected to register the highest CAGR during the forecast period. The large share of this segment can be attributed t